News
Tranquis Therapeutics Launches with $30 Million Series A Funding to Advance Novel Immuno-Neurology Approach to Treating Neurodegenerative and Aging-related Diseases
Tranquis Therapeutics are committed to the discovery and development of innovative medicines with the potential to revolutionize the management of neurodegenerative and aging-related diseases.
Biotech startup announces R&D collaboration with major Japanese drug delivery company
The companies will evaluate novel formulations of drugs that have been notoriously difficult to formulate and deliver into the skin.
BioWorld: Drug developers’ Golden Ticket
BioWorld: Drug developers’ Golden Ticket, worth a lot more than a tour of a candy manufacturing plant
Nitrome Biosciences Raises $38M Series A Financing
Read online article at BUSINESS WIRE San Francisco, Calif., April 21, 2020 /BUSINESS WI [...]
Life Science Entrepreneurs Moving Into New Biotech Incubator
Home to 19 entrepreneurs already, up to 50 companies expected soon.
Third MBC BioLab Opens in Bay Area
Home to 19 entrepreneurs already, up to 50 companies expected soon.
CellFE Raises $3.6M in Seed Round
Read online article at YAHOO finance SAN CARLOS, Calif., Jan. 16, 2020 /PRNewswire/ -- [...]
Mammoth Biosciences Raises $45 Million For Crispr Diagnostics
And Its Tech Is Already Being Used Against Coronavirus Mammoth Biosciences is a MBC B [...]
How a biotech incubator is helping Big Pharma punch ‘golden tickets’ for startups
By Ron Leuty – Staff Reporter, San Francisco Business Times Dec 9, 2019, 2:16pm PS [...]
LogicInk appears on “The World According to Jeff Goldblum”, new series on Disney+
MBC BioLabs resident company, LogicInk, appeared on the Disney+ streaming platform, [...]
Co-founder and CEO of Mammoth Biosciences on Fortune’s 2019 40 Under 40
Trevor Martin Courtesy of Molly Jorgensen - Mammoth Biosciences Mammoth Biosciences [...]
An early taste of Wild Type Salmon
Wild Type’s lab-grown salmon product. Source: Wild Type Inc. Read original article [...]
ViewPoint
ViewPoint develops a nonsurgical route to cataract treatment.
MBC BioLab’s first company, Alector, is getting ready to go public
Alector moved into MBC BioLabs on the day we opened our doors, and now just over fi [...]
Cypre and Molecular Devices sign co-marketing agreement to collaborate on delivering solutions for screening biologically relevant assays
Kolin Hribar, PhD, CEO and Founder of Cypre Inc. with their Symphony®/VersaGel® Cy [...]
Peninsula Alzheimer’s fighter hunts $150 million IPO
Alector's Arnon Rosenthal (left) and Sabah Oney. TODD JOHNSON | SAN FRANCISCO BUSINESS T [...]
Prellis Biologics and CELLINK Sign Partnership
Prellis Biologics and CELLINK Sign Partnership Prellis Biologics and CELLINK sign pa [...]
Mammoth Biosciences Featured on Forbes 30 Under 30
Mammoth Biosciences Featured on Forbes 30 Under 30 Congratulations to Trevor Martin, [...]
Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine
After completing their graduate work at Stanford, Trevor Martin and Ashley Tehranchi took [...]
MBC BioLabs’ new San Carlos site has now welcomed fourteen companies
We launched the first phase of our new campus in San Carlos on May 1, and we have now on- [...]
LI-COR places flagship infrared imaging system in San Francisco and San Carlos
Expanding the capabilities of our FastTrack Core, LI-COR has placed their Odyssey CLx infr [...]
Female Founders in Science
On June 26, Reshma Khilnani (Co-CEO, Droplet Health) hosted a standing-room-only panel dis [...]
Implantable 3D-printed organs could be coming sooner than you think
by Jonathan Shieber @jshieber, June 25, 2018Read article at TechcrunchAt MBC Biolabs, an i [...]